Form 4 Tracker
Martin Wilson

General Counsel · 8 filings · Latest: Sep 11, 2026

ROCKET PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RCKT
Martin WilsonGeneral CounselSep 11, 2026
Sale
$3.4075,364$256.5K598,489
RCKT
Wilson Martin—Sep 11, 2026
Proposed Sale
$3.4075,364$256.5K—
RCKT
Martin WilsonGeneral CounselAug 18, 2026
Sale
$3.38631$2.1K673,853
RCKT
Wilson Martin—Aug 18, 2026
Proposed Sale
$3.38631$2.1K—
RCKT
Martin WilsonGeneral CounselAug 13, 2026
Sale
$3.383,493$11.8K674,484
RCKT
Wilson Martin—Aug 13, 2026
Proposed Sale
$3.383,493$11.8K—
RCKT
Martin WilsonGeneral CounselMay 19, 2026
Sale
$3.01662$2.0K677,977
RCKT
Wilson Martin—May 19, 2026
Proposed Sale
$3.01662$2.0K—
RCKT
Martin WilsonGeneral CounselMay 13, 2026
Sale
$3.613,361$12.1K678,639
RCKT
Wilson Martin—May 13, 2026
Proposed Sale
$3.613,361$12.1K—
RCKT
Martin WilsonGeneral CounselFeb 18, 2026
Sale
$3.341,376$4.6K682,000
RCKT
Martin WilsonGeneral CounselFeb 13, 2026
Sale
$3.3112,253$40.6K683,376
RCKT
Wilson Martin—Feb 18, 2026
Proposed Sale
$3.341,376$4.6K—
RCKT
Wilson Martin—Feb 13, 2026
Proposed Sale
$3.3112,253$40.6K—
RCKT
Wilson Martin—Nov 18, 2025
Proposed Sale
$2.981,646$4.9K—
RCKT
Wilson Martin—Aug 19, 2025
Proposed Sale
$3.00588$1.8K—
RCKT
Wilson Martin—Aug 18, 2025
Proposed Sale
$3.071,004$3.1K—
RCKT
Wilson Martin—Aug 14, 2025
Proposed Sale
$3.0212,109$36.6K—
RCKT
Wilson Martin—May 20, 2025
Proposed Sale
$6.45587$3.8K—
RCKT
Wilson Martin—May 16, 2025
Proposed Sale
$6.53946$6.2K—

Page 1 of 2

Next →